Citace podle APA (7th ed.)

Price, M. Z., & Price, R. L. (2023). Authors’ Reply to Pande et al. Comment on 'Extended-Release Viloxazine Compared to Atomoxetine for Attention Deficit Hyperactivity Disorder'. CNS Drugs, 37, 939-940. https://doi.org/10.1007/s40263-023-01035-2

Citace podle Chicago (17th ed.)

Price, Maxwell Z., a Richard L. Price. "Authors’ Reply to Pande Et Al. Comment on 'Extended-Release Viloxazine Compared to Atomoxetine for Attention Deficit Hyperactivity Disorder'." CNS Drugs 37 (2023): 939-940. https://doi.org/10.1007/s40263-023-01035-2.

Citace podle MLA (9th ed.)

Price, Maxwell Z., a Richard L. Price. "Authors’ Reply to Pande Et Al. Comment on 'Extended-Release Viloxazine Compared to Atomoxetine for Attention Deficit Hyperactivity Disorder'." CNS Drugs, vol. 37, 2023, pp. 939-940, https://doi.org/10.1007/s40263-023-01035-2.

Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..